September 16, 2011
What is already known on this topic?
Cigarette smoking causes lung cancer in men and women. Wide variations in state tobacco control efforts, smoking prevalence, and lung cancer incidence have been observed in the United States. Lung cancer incidence has been decreasing for the past several decades among men but not among women.
What is added by this report?
Lung cancer incidence is beginning to decrease among women and is continuing to decrease among men in most states. Lung cancer rates are declining more rapidly in the West, which corresponds with smoking behavior; states with low smoking prevalence and high quit ratios are concentrated in this region.
What are the implications for public health practice?
Decreases in lung cancer incidence provide compelling evidence for state tobacco control policies, such as increasing tobacco excise taxes, enacting smoke-free laws, and funding policies to assist smokers in quitting. To continue these decreases in lung cancer incidence, current tobacco control funding for states needs to be increased to implement and sustain successful programs to reduce cigarette smoking and secondhand smoke exposure.
Please consider attending the Kites for a Cure™, on Folly Beach, an extraordinary family event in honor of Keisha Kirkland.
Dr. Keisha Kirkland, was diagnosed with Stage 3 Lung Cancer. As a healthy, athletic, non-smoker, we were all shocked at this devastating news. Keisha and her husband, former Clemson and NFL pro-bowl linebacker, Levon Kirkland have partnered with the national non-profit organization Uniting Against Lung Cancer (UALC) and all proceeds from this event will benefit the research programs of UALC.
Kites for a Cure will gather families and friends together to enjoy a beautiful afternoon on the beach, while bringing greater lung cancer awareness to Folly Beach area.
With a $25.00 donation, you will receive a kite you can decorate and a T-shirt. Event will take place in front of Tides Folly Beach
TRENTON, N.J. (AP) - A much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according to research presented Sunday.
The drug, called crizotinib, would be the first targeted treatment for the roughly 50,000 people who get this cancer each year worldwide. It might eventually produce annual revenue for Pfizer exceeding $2 billion.
The first overall survival data for patients with advanced non-small cell lung cancer treated with the drug, called crizotinib, showed 74 percent were still alive after a year and 54 percent after two years, researchers announced at a huge cancer specialists conference.
Median overall survival, a key measure, hasn't been determined because more than half the 82 patients are still alive.
Nearly three hundred people riding to combat lung cancer Saturday afternoon at Ryan's Ride.
They braved the hot temps to help raise money for Richland County Deputy Mark Ryan who's battling stage four lung cancer.
Sheriff Leon Lott invited folks from across the Midlands to take part.
Ryan is the single father of three daughters.
Organizers say the event raised a total of $10,315.
The money will help with Ryan's mounting medical bills.
"I think without today's event it would make or break him. It's vital to him getting his medical bills paid and its just great to see this event happen for him in his honor," says Master Deputy James Stone.
Participants signed up at Rays Place in Ballentine and than started to ride around Lake Murray.
The second benefit ride will take place July 23, 2011. For more information about the event call 803-309-8888.
Orlando Business Journal
Date: Wednesday, June 1, 2011, 3:10pm EDT
Orlando Health launched a lung cancer screening pilot program June 1 targeted at smokers and ex-smokers.
The pilot program at M.D. Anderson Cancer Center-Orlando’s Rod Taylor Thoracic Care Center will focus on current and former smokers age 55 to 74, and will use low-dose radiation and CT scans to look for nodules
that don’t typically show up on X-rays. The hospital expects 20 percent of the people screened to need further testing and 2 percent to need treatment for lung cancer.
More than 18,000 people in Florida are expected to be diagnosed with lung cancer in 2011.
The cost of the test will be discounted from $1,500 to $375.